Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets

被引:121
|
作者
Schober, A
Zernecke, A
Liehn, EA
von Hundelshausen, P
Knarren, S
Kuziel, WA
Weber, C
机构
[1] Rhein Westfal TH Aachen, Univ Hosp, Dept Mol Cardiovasc Res, Aachen, Germany
[2] Rhein Westfal TH Aachen, Univ Hosp, Dept Cardiol, Aachen, Germany
[3] Univ Texas, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA
关键词
inflammation; restenosis; platelets; vascular biology; monocyte chemoattractant protein-1;
D O I
10.1161/01.RES.0000149518.86865.3e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monocyte chemoattractant protein-1 (also known as CC chemokine ligand 2 [CCL2]) and its receptor CC chemokine receptor 2 (CCR2) play a central role in the inflammatory response and neointimal formation after vascular injury. In the context of hyperlipidemia, this appears to involve neointimal monocyte infiltration. Hence, we investigated the function of the CCL2/CCR2 axis in early monocyte recruitment to injured arteries. Wire-induced injury of the carotid artery in apoE(-/-) mice caused a rapid increase of JE/CCL2 protein in the vessel wall peaking at 24 hours after injury, whereas serum JE/CCL2 was increased solely at 6 hours and blood cell-associated levels were unaltered, as demonstrated by enzyme-linked immunosorbent assay. Immunohistochemistry revealed intense staining for JE/CCL2 in smooth muscle cells (SMCs) and in association with platelets adherent to the denuded vessel wall 24 hours after injury. In vitro, exogenous or SMC-derived JE/CCL2 binds to the platelet surface and triggers monocyte arrest on adherent platelets but not on SMCs in flow assays. Accordingly, monocyte arrest in ex vivo perfused apoE(-/-) carotid arteries isolated 24 hours after injury was profoundly inhibited by pretreatment with a JE/CCL2 antibody. In CCR2(-/-)/ apoE(-/-) mice, neointimal plaque area was reduced by 47% compared with CCR2(+/+)/ apoE(-/-) mice. Moreover, CCR2 deletion markedly decreased neointimal macrophage content while expanding SMC content. Vascular JE/CCL2 expressed by SMCs and immobilized by adherent platelets after endothelial denudation is crucial for mediating early monocyte recruitment to injured arteries in hyperlipidemic mice. This mechanism may explain reduced neointimal macrophage infiltration and lesion formation in CCR2-deficient apoE(-/-) mice.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [11] Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury
    Ping Xu
    Feng Zhang
    Min-min Chang
    Cheng Zhong
    Cheng-Hong Sun
    Hao-Ran Zhu
    Jing-Chun Yao
    Zhi-Zhong Li
    Si-Tao Li
    Wen-Cai Zhang
    Guo-Dong Sun
    Journal of Neuroinflammation, 18
  • [12] The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
    Guo, Shan
    Zhang, Qi
    Guo, Yingjie
    Yin, Xiaoyan
    Zhang, Peng
    Mao, Tao
    Tian, Zibin
    Li, Xiaoyu
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [13] Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
    Sanford, Dominic E.
    Belt, Brian A.
    Panni, Roheena Z.
    Mayer, Allese
    Deshpande, Anjali D.
    Carpenter, Danielle
    Mitchem, Jonathan B.
    Plambeck-Suess, Stacey M.
    Worley, Lori A.
    Goetz, Brian D.
    Wang-Gillam, Andrea
    Eberlein, Timothy J.
    Denardo, David G.
    Goedegebuure, Simon Peter
    Linehan, David C.
    CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3404 - 3415
  • [14] The Role of the CCL2/CCR2 Axis in Mouse Mast Cell Migration In Vitro and In Vivo
    Collington, Sarah J.
    Hallgren, Jenny
    Pease, James E.
    Jones, Tatiana G.
    Rollins, Barrett J.
    Westwick, John
    Austen, K. Frank
    Williams, Timothy J.
    Gurish, Michael F.
    Weller, Charlotte L.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (11): : 6114 - 6123
  • [15] CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
    Huang, Bo
    Lei, Zhang
    Zhao, Jie
    Gong, Wei
    Liu, Jinwen
    Chen, Zhenyong
    Liu, Yi
    Li, Dong
    Yuan, Ye
    Zhang, Gui-Mei
    Feng, Zuo-Hua
    CANCER LETTERS, 2007, 252 (01) : 86 - 92
  • [16] Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
    Bose, Shambhunath
    Cho, Jungsook
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (09) : 1039 - 1050
  • [17] Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
    Shambhunath Bose
    Jungsook Cho
    Archives of Pharmacal Research, 2013, 36 : 1039 - 1050
  • [18] Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches
    Moadab, Fatemeh
    Khorramdelazad, Hossein
    Abbasifard, Mitra
    LIFE SCIENCES, 2021, 269
  • [19] Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia
    Pang, Yangyang
    Li, Haoran
    Gong, Yuwen
    Jing, Suoshi
    Peng, Cheng
    Liu, Wei
    Zhao, Youli
    Wang, Hanzhang
    Kaushik, Dharam
    Rodriguez, Ronald
    Wang, Zhiping
    ONCOLOGY REPORTS, 2019, 41 (04) : 2491 - 2501
  • [20] Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
    Sorensen, TL
    Ransohoff, RM
    Strieter, RM
    Sellebjerg, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (07) : 445 - 449